DMS ensures quality of nonprescription drugs used domestically

[webfact]

DMS ensures quality of nonprescription drugs used domestically

 

BANGKOK, 12 July 2017 (NNT) – The Department of Medical Sciences (DMS) has published the Green Book 2017, listing all pharmaceutical products and manufacturers that have passed evaluation by the DMS for their quality standards. 

DMS Director General Sukhum Kanchanaphimai disclosed that the DMS has collaborated with government hospitals nationwide to collect and verify the quality of 572 samples of pharmaceutical products used in hospitals. The results are then assessed to enable The DMS will assess the results to verify all pharmaceutical products are in line pharmacopeial standards.

 

All the products have been listed in the Green Book lists all products in its “List of Quality Pharmaceutical Products and Manufacturers”, which includes their generic names and all pharmaceutical companies holding at least three production lots of the pharmacopeial quality-approved products with their registration number. 

Up until now, two editions of the Green Book have been published and distributed to the general public. 

In fiscal year 2007, the DMS, Bureau of Drug and Narcotic and Regional Medical Sciences Centers selected 60 items of modern and herbal products for quality assurance. The selection criteria was based on information from “the National Essential Drugs List” including pharmaceutical products which had not been subject to quality assurance over the past five years and products with stability problem.

 

The results were then assessed and published in the following edition of the Green Book to facilitate purchasing decisions or to be used for other beneficial purposes. Substandard pharmaceutical products will be reported to the Food and Drug Administration. 

Interested individuals can download Green Book 2017 from the website of the DMS' Bureau of Drug and Narcotic or www.tumdee.org/alert/  and https://goo.gl/msEP0h

 

-- nnt 2017-07-12

[Cadbury]

I am not sure what to make of all this. On the face of it its seems a good thing to have all certified "quality" medicines registered in the 2017 edition of the Green Book as a people's reference. 

 

Although there is no mention of it something inside me tells me money  is at the bottom of all this somewhere. It has to be; this is Thailand after all. 

 

Maybe I am being cynical but I am curious as to how much it costs pharmaceutical companies to have their products "certified" and listed in the "new" Green Book. I suspect there is little choice for bona fide drug companies other than to have their name in the book and for that privilege they are sure to have to pay. 

 

[little mary sunshine]

Quality assurance program, excellent idea.

[johng]

Does this "green book" saga explain the disappearance of Aspirin from the pharmacy shelf's ? ?

Will Aspirin 500mg ever be available in Thailand again maybe Bayer didn't make it into the "green book" ?